当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
ASCENIV, Immune Globulin Intravenous, Human-slra
申请企业
ADMA Biologics, Inc.
药品名称
ASCENIV, Immune Globulin Intravenous, Human-slra
承诺描述
Deferred pediatric study under PREA for the treatment of primary immunodeficiency in pediatric patients ages 2 to 12 years.
承诺状态描述
The study has not been initiated, but does not meet the criterion for delayed